Garry Morefield

Dr. Garry Morefield has been the President at VaxForm, LLC for 10 years. Prior to founding VaxForm, Dr. Morefield was the head of formulation and stability at Sanofi Pasteur. At Sanofi Pasteur he worked on a variety of bacterial and viral vaccine targets from pre-clinical development through clinical phases as well as marketed products. These included seasonal and pandemic influenza, pneumococcal and meningococcal conjugates, meningococcal group B, C. difficile, hepatitis B, inactivated polio, diphtheria, tetanus, pertussis as well as combination vaccine products.

Dr. Morefield has additional experience with biodefense vaccine development while working at the United States Army Medical Research Institute of Infectious Disease. While there he participated in formulation development of Streptococcal enterotoxin B, anthrax, plague, and botulinum neurotoxin A vaccines. Additionally, he has particular expertise in adjuvant development and production including TLR and CTL agonists, squalene-based emulsions, and aluminum salts. Dr. Morefield is a recognized expert in aluminum adjuvants giving multiple talks at research conferences, private company workshops, and as an expert witness in patent prosecutions.